Jannsen Pharmaceutica NV
Patent Applications and Registrations
Patent applications and USPTO patent grants for Jannsen Pharmaceutica NV.The latest application filed is for "novel compounds as opioid receptor modulators".
- Jannsen Pharmaceutica NV - Beerse BE
- Jannsen Pharmaceutica, N.V. - Beerse N/A BE
| Patent | Date |
|---|---|
| Antibodies to pyroglutamate amyloid-.beta. and uses thereof Grant 10,519,223 - Mercken , et al. Dec | 2019-12-31 |
| Novel Compounds As Opioid Receptor Modulators App 20160030393 - BRESLIN; HENRY J. ; et al. | 2016-02-04 |
| Compounds as opioid receptor modulators Grant 9,205,076 - Breslin , et al. December 8, 2 | 2015-12-08 |
| Novel Compounds As Opioid Receptor Modulators App 20140256779 - Breslin; Henry J. ; et al. | 2014-09-11 |
| Compounds as opioid receptor modulators Grant 8,772,325 - Breslin , et al. July 8, 2 | 2014-07-08 |
| Novel Compounds As Opioid Receptor Modulators App 20140039024 - BRESLIN; HENRY J. ; et al. | 2014-02-06 |
| Compounds as opioid receptor modulators Grant 8,609,709 - Breslin , et al. December 17, 2 | 2013-12-17 |
| Novel Compounds As Opioid Receptor Modulators App 20130090478 - BRESLIN; HENRY J. ; et al. | 2013-04-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 